Madam Chair, could the minister explain to the opposition health critic the fact that a bill presented in the House, prior to it becoming law, goes to the committee, which can study the bill? It generally is not very restricted in the elements that it studies outside the bill.
Also, the minister alluded to the fact that it has been on the intense list of the health committee for a long time. At every committee, quite often at the instigation of the member opposite, we deal with a whole bunch of motions and things that are sometimes brought there for political intent. We spend a lot of time on that rather doing the work of the committee. Work like this would be important.
The minister perhaps could consider what the health critic would find objectionable and he could take advantage of that and consult Canadians about it. Is it the question of having a drug supply network, knowing exactly the state of our pharmaceuticals in our country? Is it the fact of restricting the export of drugs when it would be hazardous to human health in Canada? Is it the fact of having proper links or established relationships between physicians and patients prior to prescribing them potentially dangerous drugs?